Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.
We have some exciting news: Nominations are now open for MIT Technology Review’s 2026 Innovators Under 35 competition. This ...
Modern Engineering Marvels on MSN
X30 Robot Dogs Redefine Disaster Rescue with Precision and Resilience
Robots should work for humans, so they need to be able to interact with our environment and perceive our world the way we do, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback